APO Research
Talk to an analyst

APO RESEARCH · REPORT

Epigenome Analysis Services

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Epigenome Analysis Services Market Analysis and Forecast 2026-2032

2 May 2026201 pages

Choose your research edition.

Industry ResearchEpigenome Analysis Services Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Epigenome Analysis Services Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Epigenome Analysis Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Epigenome Analysis Services Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Epigenome Analysis Services Market Analysis and Forecast 2026-2032201 pages · $4,950 USD

Market perspective

The global Epigenome Analysis Services market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Epigenome Analysis Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Epigenome Analysis Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Epigenome Analysis Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Epigenome Analysis Services is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Epigenome Analysis Services include Cellcentric, Syndax, Illumina, Merck, QIAGEN, F. Hoffmann-La Roche, Eisai, Abcam and Diagenode, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Epigenome Analysis Services, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Epigenome Analysis Services, also provides the revenue of main regions and countries. Of the upcoming market potential for Epigenome Analysis Services, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Epigenome Analysis Services revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Epigenome Analysis Services market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Epigenome Analysis Services revenue, projected growth trends, production technology, application and end-user industry.

Epigenome Analysis Services Segment by Company

Cellcentric

Syndax

Illumina

Merck

QIAGEN

F. Hoffmann-La Roche

Eisai

Abcam

Diagenode

Active Motif

Zymo Research Corporation

Thermo Fisher Scientific

Enzo Life Sciences

EpiGentek Group

New England Biolabs

Epizyme

Domainex

Agilent Technologies

AsisChem

Epigenome Analysis Services Segment by Type

DNA Methylation Analysis

Analysis of DNA Interactions

Chromatin Accessibility

Conformation Assays

Epigenome Analysis Services Segment by Application

Research Institutes

Pharmaceutical Companies

Biotechnology Companies

Others

Epigenome Analysis Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Epigenome Analysis Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Epigenome Analysis Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Epigenome Analysis Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Epigenome Analysis Services in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Epigenome Analysis Services company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Epigenome Analysis Services revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Epigenome Analysis Services Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. DNA Methylation Analysis Major Player Table 3. Analysis of DNA Interactions Major Player Table 4. Chromatin Accessibility Major Player Table 5. Conformation Assays Major Player Table 6. Global Epigenome Analysis Services Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Research Institutes Major Player Table 8. Pharmaceutical Companies Major Player Table 9. Biotechnology Companies Major Player Table 10. Others Major Player Table 11. Epigenome Analysis Services Industry Trends Table 12. Epigenome Analysis Services Industry Drivers Table 13. Epigenome Analysis Services Industry Opportunities and Challenges Table 14. Epigenome Analysis Services Industry Restraints Table 15. Global Epigenome Analysis Services Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 16. Global Epigenome Analysis Services Market Size by Region (2021-2026) & (US$ Million) Table 17. Global Epigenome Analysis Services Market Share by Region (2021-2026) Table 18. Global Epigenome Analysis Services Market Size by Region (2027-2032) & (US$ Million) Table 19. Global Epigenome Analysis Services Market Share by Region (2027-2032) Table 20. Global Epigenome Analysis Services Revenue by Players (US$ Million) & (2021-2026) Table 21. Global Epigenome Analysis Services Revenue Market Share by Players (2021-2026) Table 22. Global Epigenome Analysis Services Key Players Ranking, 2024 VS 2025 VS 2026 Table 23. Global Epigenome Analysis Services Key Players Headquarters & Area Served Table 24. Global Epigenome Analysis Services Players, Product Type & Application Table 25. Global Epigenome Analysis Services Players Establishment Date Table 26. Global Players Market Concentration Ratio (CR5 and HHI) Table 27. Global Epigenome Analysis Services by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 28. Global Epigenome Analysis Services Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Epigenome Analysis Services Revenue by Type (2021-2026) & (US$ Million) Table 30. Global Epigenome Analysis Services Revenue by Type (2027-2032) & (US$ Million) Table 31. Global Epigenome Analysis Services Revenue Market Share by Type (2021-2026) Table 32. Global Epigenome Analysis Services Revenue Market Share by Type (2027-2032) Table 33. Global Epigenome Analysis Services Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Epigenome Analysis Services Revenue by Application (2021-2026) & (US$ Million) Table 35. Global Epigenome Analysis Services Revenue by Application (2027-2032) & (US$ Million) Table 36. Global Epigenome Analysis Services Revenue Market Share by Application (2021-2026) Table 37. Global Epigenome Analysis Services Revenue Market Share by Application (2027-2032) Table 38. Cellcentric Company Information Table 39. Cellcentric Business Overview Table 40. Cellcentric Epigenome Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. Cellcentric Epigenome Analysis Services Product Portfolio Table 42. Cellcentric Recent Development Table 43. Syndax Company Information Table 44. Syndax Business Overview Table 45. Syndax Epigenome Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Syndax Epigenome Analysis Services Product Portfolio Table 47. Syndax Recent Development Table 48. Illumina Company Information Table 49. Illumina Business Overview Table 50. Illumina Epigenome Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Illumina Epigenome Analysis Services Product Portfolio Table 52. Illumina Recent Development Table 53. Merck Company Information Table 54. Merck Business Overview Table 55. Merck Epigenome Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. Merck Epigenome Analysis Services Product Portfolio Table 57. Merck Recent Development Table 58. QIAGEN Company Information Table 59. QIAGEN Business Overview Table 60. QIAGEN Epigenome Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. QIAGEN Epigenome Analysis Services Product Portfolio Table 62. QIAGEN Recent Development Table 63. F. Hoffmann-La Roche Company Information Table 64. F. Hoffmann-La Roche Business Overview Table 65. F. Hoffmann-La Roche Epigenome Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. F. Hoffmann-La Roche Epigenome Analysis Services Product Portfolio Table 67. F. Hoffmann-La Roche Recent Development Table 68. Eisai Company Information Table 69. Eisai Business Overview Table 70. Eisai Epigenome Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. Eisai Epigenome Analysis Services Product Portfolio Table 72. Eisai Recent Development Table 73. Abcam Company Information Table 74. Abcam Business Overview Table 75. Abcam Epigenome Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. Abcam Epigenome Analysis Services Product Portfolio Table 77. Abcam Recent Development Table 78. Diagenode Company Information Table 79. Diagenode Business Overview Table 80. Diagenode Epigenome Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. Diagenode Epigenome Analysis Services Product Portfolio Table 82. Diagenode Recent Development Table 83. Active Motif Company Information Table 84. Active Motif Business Overview Table 85. Active Motif Epigenome Analysis Services Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. Active Motif Epigenome Analysis Services Product Portfolio Table 87. Active Motif Recent Development Table 88. Zymo Research Corporation Company Information Table 89. Zymo Research Corporation Business Overview Table 90. Zymo Research Corporation Epigenome Analysis Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. Zymo Research Corporation Epigenome Analysis Services Product Portfolio Table 92. Zymo Research Corporation Recent Development Table 93. Thermo Fisher Scientific Company Information Table 94. Thermo Fisher Scientific Business Overview Table 95. Thermo Fisher Scientific Epigenome Analysis Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Thermo Fisher Scientific Epigenome Analysis Services Product Portfolio Table 97. Thermo Fisher Scientific Recent Development Table 98. Enzo Life Sciences Company Information Table 99. Enzo Life Sciences Business Overview Table 100. Enzo Life Sciences Epigenome Analysis Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Enzo Life Sciences Epigenome Analysis Services Product Portfolio Table 102. Enzo Life Sciences Recent Development Table 103. EpiGentek Group Company Information Table 104. EpiGentek Group Business Overview Table 105. EpiGentek Group Epigenome Analysis Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. EpiGentek Group Epigenome Analysis Services Product Portfolio Table 107. EpiGentek Group Recent Development Table 108. New England Biolabs Company Information Table 109. New England Biolabs Business Overview Table 110. New England Biolabs Epigenome Analysis Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. New England Biolabs Epigenome Analysis Services Product Portfolio Table 112. New England Biolabs Recent Development Table 113. Epizyme Company Information Table 114. Epizyme Business Overview Table 115. Epizyme Epigenome Analysis Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. Epizyme Epigenome Analysis Services Product Portfolio Table 117. Epizyme Recent Development Table 118. Domainex Company Information Table 119. Domainex Business Overview Table 120. Domainex Epigenome Analysis Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 121. Domainex Epigenome Analysis Services Product Portfolio Table 122. Domainex Recent Development Table 123. Agilent Technologies Company Information Table 124. Agilent Technologies Business Overview Table 125. Agilent Technologies Epigenome Analysis Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 126. Agilent Technologies Epigenome Analysis Services Product Portfolio Table 127. Agilent Technologies Recent Development Table 128. AsisChem Company Information Table 129. AsisChem Business Overview Table 130. AsisChem Epigenome Analysis Services Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 131. AsisChem Epigenome Analysis Services Product Portfolio Table 132. AsisChem Recent Development Table 133. North America Epigenome Analysis Services Revenue by Type (2021-2026) & (US$ Million) Table 134. North America Epigenome Analysis Services Revenue by Type (2027-2032) & (US$ Million) Table 135. North America Epigenome Analysis Services Revenue by Application (2021-2026) & (US$ Million) Table 136. North America Epigenome Analysis Services Revenue by Application (2027-2032) & (US$ Million) Table 137. North America Epigenome Analysis Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 138. North America Epigenome Analysis Services Revenue by Country (2021-2026) & (US$ Million) Table 139. North America Epigenome Analysis Services Revenue by Country (US$ Million) & (2027-2032) Table 140. Europe Epigenome Analysis Services Revenue by Type (2021-2026) & (US$ Million) Table 141. Europe Epigenome Analysis Services Revenue by Type (2027-2032) & (US$ Million) Table 142. Europe Epigenome Analysis Services Revenue by Application (2021-2026) & (US$ Million) Table 143. Europe Epigenome Analysis Services Revenue by Application (2027-2032) & (US$ Million) Table 144. Europe Epigenome Analysis Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 145. Europe Epigenome Analysis Services Revenue by Country (2021-2026) & (US$ Million) Table 146. Europe Epigenome Analysis Services Revenue by Country (US$ Million) & (2027-2032) Table 147. China Epigenome Analysis Services Revenue by Type (2021-2026) & (US$ Million) Table 148. China Epigenome Analysis Services Revenue by Type (2027-2032) & (US$ Million) Table 149. China Epigenome Analysis Services Revenue by Application (2021-2026) & (US$ Million) Table 150. China Epigenome Analysis Services Revenue by Application (2027-2032) & (US$ Million) Table 151. Asia Epigenome Analysis Services Revenue by Type (2021-2026) & (US$ Million) Table 152. Asia Epigenome Analysis Services Revenue by Type (2027-2032) & (US$ Million) Table 153. Asia Epigenome Analysis Services Revenue by Application (2021-2026) & (US$ Million) Table 154. Asia Epigenome Analysis Services Revenue by Application (2027-2032) & (US$ Million) Table 155. Asia Epigenome Analysis Services Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 156. Asia Epigenome Analysis Services Revenue by Region (US$ Million) & (2021-2026) Table 157. Asia Epigenome Analysis Services Revenue by Region (US$ Million) & (2027-2032) Table 158. SAMEA Epigenome Analysis Services Revenue by Type (2021-2026) & (US$ Million) Table 159. SAMEA Epigenome Analysis Services Revenue by Type (2027-2032) & (US$ Million) Table 160. SAMEA Epigenome Analysis Services Revenue by Application (2021-2026) & (US$ Million) Table 161. SAMEA Epigenome Analysis Services Revenue by Application (2027-2032) & (US$ Million) Table 162. SAMEA Epigenome Analysis Services Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 163. SAMEA Epigenome Analysis Services Revenue by Country (2021-2026) & (US$ Million) Table 164. SAMEA Epigenome Analysis Services Revenue by Country (US$ Million) & (2027-2032) Table 165. Research Programs/Design for This Report Table 166. Authors List of This Report Table 167. Secondary Sources Table 168. Primary Sources List of Figures Figure 1. Epigenome Analysis Services Image Figure 2. Global Epigenome Analysis Services Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Epigenome Analysis Services Market Size Share 2021 VS 2025 VS 2032 Figure 4. DNA Methylation Analysis Image Figure 5. Analysis of DNA Interactions Image Figure 6. Chromatin Accessibility Image Figure 7. Conformation Assays Image Figure 8. Global Epigenome Analysis Services Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Epigenome Analysis Services Market Size Share 2021 VS 2025 VS 2032 Figure 10. Research Institutes Image Figure 11. Pharmaceutical Companies Image Figure 12. Biotechnology Companies Image Figure 13. Others Image Figure 14. Global Epigenome Analysis Services Market Size (US$ Million) & (2021-2032) Figure 15. Global Epigenome Analysis Services Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Epigenome Analysis Services Market Share by Region: 2021 VS 2025 VS 2032 Figure 17. Global Epigenome Analysis Services Players Revenue Share Top 10 and Top 5 in 2025 Figure 18. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Epigenome Analysis Services Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Epigenome Analysis Services Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global Epigenome Analysis Services Revenue Market Share by Type (2021-2032) Figure 22. Global Epigenome Analysis Services Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Epigenome Analysis Services Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 24. Global Epigenome Analysis Services Revenue Market Share by Application (2021-2032) Figure 25. North America Epigenome Analysis Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 26. North America Epigenome Analysis Services Revenue Share by Type (2021-2032) Figure 27. North America Epigenome Analysis Services Revenue Share by Application (2021-2032) Figure 28. North America Epigenome Analysis Services Revenue Share by Country (2021-2032) Figure 29. United States Epigenome Analysis Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Canada Epigenome Analysis Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Mexico Epigenome Analysis Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Europe Epigenome Analysis Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 33. Europe Epigenome Analysis Services Revenue Share by Type (2021-2032) Figure 34. Europe Epigenome Analysis Services Revenue Share by Application (2021-2032) Figure 35. Europe Epigenome Analysis Services Revenue Share by Country (2021-2032) Figure 36. Germany Epigenome Analysis Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. France Epigenome Analysis Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. U.K. Epigenome Analysis Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Italy Epigenome Analysis Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Spain Epigenome Analysis Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Russia Epigenome Analysis Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Netherlands Epigenome Analysis Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Nordic Countries Epigenome Analysis Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. China Epigenome Analysis Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. China Epigenome Analysis Services Revenue Share by Type (2021-2032) Figure 46. China Epigenome Analysis Services Revenue Share by Application (2021-2032) Figure 47. Asia Epigenome Analysis Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. Asia Epigenome Analysis Services Revenue Share by Type (2021-2032) Figure 49. Asia Epigenome Analysis Services Revenue Share by Application (2021-2032) Figure 50. Asia Epigenome Analysis Services Revenue Share by Region (2021-2032) Figure 51. Japan Epigenome Analysis Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. South Korea Epigenome Analysis Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. India Epigenome Analysis Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Australia Epigenome Analysis Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Taiwan Epigenome Analysis Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Southeast Asia Epigenome Analysis Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. SAMEA Epigenome Analysis Services Revenue YoY Growth (2021-2032) & (US$ Million) Figure 58. SAMEA Epigenome Analysis Services Revenue Share by Type (2021-2032) Figure 59. SAMEA Epigenome Analysis Services Revenue Share by Application (2021-2032) Figure 60. SAMEA Epigenome Analysis Services Revenue Share by Country (2021-2032) Figure 61. Brazil Epigenome Analysis Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Argentina Epigenome Analysis Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Chile Epigenome Analysis Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Colombia Epigenome Analysis Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Peru Epigenome Analysis Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Saudi Arabia Epigenome Analysis Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Israel Epigenome Analysis Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. UAE Epigenome Analysis Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Turkey Epigenome Analysis Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Iran Epigenome Analysis Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Egypt Epigenome Analysis Services Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • DNA Methylation Analysis
  • Analysis of DNA Interactions
  • Chromatin Accessibility
  • Conformation Assays
Applications
  • Research Institutes
  • Pharmaceutical Companies
  • Biotechnology Companies
  • Others
Companies covered
  • Cellcentric
  • Syndax
  • Illumina
  • Merck
  • QIAGEN
  • F. Hoffmann-La Roche
  • Eisai
  • Abcam
  • Diagenode
  • Active Motif
  • Zymo Research Corporation
  • Thermo Fisher Scientific
  • Enzo Life Sciences
  • EpiGentek Group
  • New England Biolabs
  • Epizyme
  • Domainex
  • Agilent Technologies
  • AsisChem

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Epigenome Analysis Services Market by Type
  3. 1.2.1 Global Epigenome Analysis Services Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 DNA Methylation Analysis
  5. 1.2.3 Analysis of DNA Interactions
  6. 1.2.4 Chromatin Accessibility
  7. 1.2.5 Conformation Assays
  8. 1.3 Epigenome Analysis Services Market by Application
  9. 1.3.1 Global Epigenome Analysis Services Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Research Institutes
  11. 1.3.3 Pharmaceutical Companies
  12. 1.3.4 Biotechnology Companies
  13. 1.3.5 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Epigenome Analysis Services Market Dynamics
  1. 2.1 Epigenome Analysis Services Industry Trends
  2. 2.2 Epigenome Analysis Services Industry Drivers
  3. 2.3 Epigenome Analysis Services Industry Opportunities and Challenges
  4. 2.4 Epigenome Analysis Services Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Epigenome Analysis Services Market Perspective (2021-2032)
  2. 3.2 Global Epigenome Analysis Services Growth Trends by Region
  3. 3.2.1 Global Epigenome Analysis Services Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Epigenome Analysis Services Market Size by Region (2021-2026)
  5. 3.2.3 Global Epigenome Analysis Services Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Epigenome Analysis Services Revenue by Players
  2. 4.1.1 Global Epigenome Analysis Services Revenue by Players (2021-2026)
  3. 4.1.2 Global Epigenome Analysis Services Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Epigenome Analysis Services Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Epigenome Analysis Services Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Epigenome Analysis Services Key Players Headquarters & Area Served
  7. 4.4 Global Epigenome Analysis Services Players, Product Type & Application
  8. 4.5 Global Epigenome Analysis Services Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Epigenome Analysis Services Market CR5 and HHI
  11. 4.6.3 2025 Epigenome Analysis Services Tier 1, Tier 2, and Tier 3
5 Epigenome Analysis Services Market Size by Type
  1. 5.1 Global Epigenome Analysis Services Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Epigenome Analysis Services Revenue by Type (2021-2032)
  3. 5.3 Global Epigenome Analysis Services Revenue Market Share by Type (2021-2032)
6 Epigenome Analysis Services Market Size by Application
  1. 6.1 Global Epigenome Analysis Services Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Epigenome Analysis Services Revenue by Application (2021-2032)
  3. 6.3 Global Epigenome Analysis Services Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Cellcentric
  2. 7.1.1 Cellcentric Company Information
  3. 7.1.2 Cellcentric Business Overview
  4. 7.1.3 Cellcentric Epigenome Analysis Services Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Cellcentric Epigenome Analysis Services Product Portfolio
  6. 7.1.5 Cellcentric Recent Developments
  7. 7.2 Syndax
  8. 7.2.1 Syndax Company Information
  9. 7.2.2 Syndax Business Overview
  10. 7.2.3 Syndax Epigenome Analysis Services Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Syndax Epigenome Analysis Services Product Portfolio
  12. 7.2.5 Syndax Recent Developments
  13. 7.3 Illumina
  14. 7.3.1 Illumina Company Information
  15. 7.3.2 Illumina Business Overview
  16. 7.3.3 Illumina Epigenome Analysis Services Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Illumina Epigenome Analysis Services Product Portfolio
  18. 7.3.5 Illumina Recent Developments
  19. 7.4 Merck
  20. 7.4.1 Merck Company Information
  21. 7.4.2 Merck Business Overview
  22. 7.4.3 Merck Epigenome Analysis Services Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Merck Epigenome Analysis Services Product Portfolio
  24. 7.4.5 Merck Recent Developments
  25. 7.5 QIAGEN
  26. 7.5.1 QIAGEN Company Information
  27. 7.5.2 QIAGEN Business Overview
  28. 7.5.3 QIAGEN Epigenome Analysis Services Revenue and Gross Margin (2021-2026)
  29. 7.5.4 QIAGEN Epigenome Analysis Services Product Portfolio
  30. 7.5.5 QIAGEN Recent Developments
  31. 7.6 F. Hoffmann-La Roche
  32. 7.6.1 F. Hoffmann-La Roche Company Information
  33. 7.6.2 F. Hoffmann-La Roche Business Overview
  34. 7.6.3 F. Hoffmann-La Roche Epigenome Analysis Services Revenue and Gross Margin (2021-2026)
  35. 7.6.4 F. Hoffmann-La Roche Epigenome Analysis Services Product Portfolio
  36. 7.6.5 F. Hoffmann-La Roche Recent Developments
  37. 7.7 Eisai
  38. 7.7.1 Eisai Company Information
  39. 7.7.2 Eisai Business Overview
  40. 7.7.3 Eisai Epigenome Analysis Services Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Eisai Epigenome Analysis Services Product Portfolio
  42. 7.7.5 Eisai Recent Developments
  43. 7.8 Abcam
  44. 7.8.1 Abcam Company Information
  45. 7.8.2 Abcam Business Overview
  46. 7.8.3 Abcam Epigenome Analysis Services Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Abcam Epigenome Analysis Services Product Portfolio
  48. 7.8.5 Abcam Recent Developments
  49. 7.9 Diagenode
  50. 7.9.1 Diagenode Company Information
  51. 7.9.2 Diagenode Business Overview
  52. 7.9.3 Diagenode Epigenome Analysis Services Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Diagenode Epigenome Analysis Services Product Portfolio
  54. 7.9.5 Diagenode Recent Developments
  55. 7.10 Active Motif
  56. 7.10.1 Active Motif Company Information
  57. 7.10.2 Active Motif Business Overview
  58. 7.10.3 Active Motif Epigenome Analysis Services Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Active Motif Epigenome Analysis Services Product Portfolio
  60. 7.10.5 Active Motif Recent Developments
  61. 7.11 Zymo Research Corporation
  62. 7.11.1 Zymo Research Corporation Company Information
  63. 7.11.2 Zymo Research Corporation Business Overview
  64. 7.11.3 Zymo Research Corporation Epigenome Analysis Services Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Zymo Research Corporation Epigenome Analysis Services Product Portfolio
  66. 7.11.5 Zymo Research Corporation Recent Developments
  67. 7.12 Thermo Fisher Scientific
  68. 7.12.1 Thermo Fisher Scientific Company Information
  69. 7.12.2 Thermo Fisher Scientific Business Overview
  70. 7.12.3 Thermo Fisher Scientific Epigenome Analysis Services Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Thermo Fisher Scientific Epigenome Analysis Services Product Portfolio
  72. 7.12.5 Thermo Fisher Scientific Recent Developments
  73. 7.13 Enzo Life Sciences
  74. 7.13.1 Enzo Life Sciences Company Information
  75. 7.13.2 Enzo Life Sciences Business Overview
  76. 7.13.3 Enzo Life Sciences Epigenome Analysis Services Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Enzo Life Sciences Epigenome Analysis Services Product Portfolio
  78. 7.13.5 Enzo Life Sciences Recent Developments
  79. 7.14 EpiGentek Group
  80. 7.14.1 EpiGentek Group Company Information
  81. 7.14.2 EpiGentek Group Business Overview
  82. 7.14.3 EpiGentek Group Epigenome Analysis Services Revenue and Gross Margin (2021-2026)
  83. 7.14.4 EpiGentek Group Epigenome Analysis Services Product Portfolio
  84. 7.14.5 EpiGentek Group Recent Developments
  85. 7.15 New England Biolabs
  86. 7.15.1 New England Biolabs Company Information
  87. 7.15.2 New England Biolabs Business Overview
  88. 7.15.3 New England Biolabs Epigenome Analysis Services Revenue and Gross Margin (2021-2026)
  89. 7.15.4 New England Biolabs Epigenome Analysis Services Product Portfolio
  90. 7.15.5 New England Biolabs Recent Developments
  91. 7.16 Epizyme
  92. 7.16.1 Epizyme Company Information
  93. 7.16.2 Epizyme Business Overview
  94. 7.16.3 Epizyme Epigenome Analysis Services Revenue and Gross Margin (2021-2026)
  95. 7.16.4 Epizyme Epigenome Analysis Services Product Portfolio
  96. 7.16.5 Epizyme Recent Developments
  97. 7.17 Domainex
  98. 7.17.1 Domainex Company Information
  99. 7.17.2 Domainex Business Overview
  100. 7.17.3 Domainex Epigenome Analysis Services Revenue and Gross Margin (2021-2026)
  101. 7.17.4 Domainex Epigenome Analysis Services Product Portfolio
  102. 7.17.5 Domainex Recent Developments
  103. 7.18 Agilent Technologies
  104. 7.18.1 Agilent Technologies Company Information
  105. 7.18.2 Agilent Technologies Business Overview
  106. 7.18.3 Agilent Technologies Epigenome Analysis Services Revenue and Gross Margin (2021-2026)
  107. 7.18.4 Agilent Technologies Epigenome Analysis Services Product Portfolio
  108. 7.18.5 Agilent Technologies Recent Developments
  109. 7.19 AsisChem
  110. 7.19.1 AsisChem Company Information
  111. 7.19.2 AsisChem Business Overview
  112. 7.19.3 AsisChem Epigenome Analysis Services Revenue and Gross Margin (2021-2026)
  113. 7.19.4 AsisChem Epigenome Analysis Services Product Portfolio
  114. 7.19.5 AsisChem Recent Developments
8 North America
  1. 8.1 North America Epigenome Analysis Services Revenue (2021-2032)
  2. 8.2 North America Epigenome Analysis Services Revenue by Type (2021-2032)
  3. 8.2.1 North America Epigenome Analysis Services Revenue by Type (2021-2026)
  4. 8.2.2 North America Epigenome Analysis Services Revenue by Type (2027-2032)
  5. 8.3 North America Epigenome Analysis Services Revenue Share by Type (2021-2032)
  6. 8.4 North America Epigenome Analysis Services Revenue by Application (2021-2032)
  7. 8.4.1 North America Epigenome Analysis Services Revenue by Application (2021-2026)
  8. 8.4.2 North America Epigenome Analysis Services Revenue by Application (2027-2032)
  9. 8.5 North America Epigenome Analysis Services Revenue Share by Application (2021-2032)
  10. 8.6 North America Epigenome Analysis Services Revenue by Country
  11. 8.6.1 North America Epigenome Analysis Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Epigenome Analysis Services Revenue by Country (2021-2026)
  13. 8.6.3 North America Epigenome Analysis Services Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Epigenome Analysis Services Revenue (2021-2032)
  2. 9.2 Europe Epigenome Analysis Services Revenue by Type (2021-2032)
  3. 9.2.1 Europe Epigenome Analysis Services Revenue by Type (2021-2026)
  4. 9.2.2 Europe Epigenome Analysis Services Revenue by Type (2027-2032)
  5. 9.3 Europe Epigenome Analysis Services Revenue Share by Type (2021-2032)
  6. 9.4 Europe Epigenome Analysis Services Revenue by Application (2021-2032)
  7. 9.4.1 Europe Epigenome Analysis Services Revenue by Application (2021-2026)
  8. 9.4.2 Europe Epigenome Analysis Services Revenue by Application (2027-2032)
  9. 9.5 Europe Epigenome Analysis Services Revenue Share by Application (2021-2032)
  10. 9.6 Europe Epigenome Analysis Services Revenue by Country
  11. 9.6.1 Europe Epigenome Analysis Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Epigenome Analysis Services Revenue by Country (2021-2026)
  13. 9.6.3 Europe Epigenome Analysis Services Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Epigenome Analysis Services Revenue (2021-2032)
  2. 10.2 China Epigenome Analysis Services Revenue by Type (2021-2032)
  3. 10.2.1 China Epigenome Analysis Services Revenue by Type (2021-2026)
  4. 10.2.2 China Epigenome Analysis Services Revenue by Type (2027-2032)
  5. 10.3 China Epigenome Analysis Services Revenue Share by Type (2021-2032)
  6. 10.4 China Epigenome Analysis Services Revenue by Application (2021-2032)
  7. 10.4.1 China Epigenome Analysis Services Revenue by Application (2021-2026)
  8. 10.4.2 China Epigenome Analysis Services Revenue by Application (2027-2032)
  9. 10.5 China Epigenome Analysis Services Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Epigenome Analysis Services Revenue (2021-2032)
  2. 11.2 Asia Epigenome Analysis Services Revenue by Type (2021-2032)
  3. 11.2.1 Asia Epigenome Analysis Services Revenue by Type (2021-2026)
  4. 11.2.2 Asia Epigenome Analysis Services Revenue by Type (2027-2032)
  5. 11.3 Asia Epigenome Analysis Services Revenue Share by Type (2021-2032)
  6. 11.4 Asia Epigenome Analysis Services Revenue by Application (2021-2032)
  7. 11.4.1 Asia Epigenome Analysis Services Revenue by Application (2021-2026)
  8. 11.4.2 Asia Epigenome Analysis Services Revenue by Application (2027-2032)
  9. 11.5 Asia Epigenome Analysis Services Revenue Share by Application (2021-2032)
  10. 11.6 Asia Epigenome Analysis Services Revenue by Country
  11. 11.6.1 Asia Epigenome Analysis Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Epigenome Analysis Services Revenue by Country (2021-2026)
  13. 11.6.3 Asia Epigenome Analysis Services Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Epigenome Analysis Services Revenue (2021-2032)
  2. 12.2 SAMEA Epigenome Analysis Services Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Epigenome Analysis Services Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Epigenome Analysis Services Revenue by Type (2027-2032)
  5. 12.3 SAMEA Epigenome Analysis Services Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Epigenome Analysis Services Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Epigenome Analysis Services Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Epigenome Analysis Services Revenue by Application (2027-2032)
  9. 12.5 SAMEA Epigenome Analysis Services Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Epigenome Analysis Services Revenue by Country
  11. 12.6.1 SAMEA Epigenome Analysis Services Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Epigenome Analysis Services Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Epigenome Analysis Services Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst